Kilitch Drugs (India) is currently trading at Rs. 155.30, up by 2.60 points or 1.70% from its previous closing of Rs. 152.70 on the BSE.
The scrip opened at Rs. 152.00 and has touched a high and low of Rs. 155.30 and Rs. 151.65 respectively. So far 761 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 175.65 on 15-Oct-2018 and a 52 week low of Rs. 70.05 on 26-Oct-2017.
Last one week high and low of the scrip stood at Rs. 169.60 and Rs. 146.15 respectively. The current market cap of the company is Rs. 234.47 crore.
The promoters holding in the company stood at 69.25%, while Non-Institutions held 30.74%.
Kilitch Drugs (India) is all set to boost its expansion plans in Africa with its first manufacturing plant in Addis Ababa, the capital city of Ethopia in Africa. The company has been successfully operating in the continent for three decades in providing pharmaceutical solutions with more than 200 products registered and 250 plus under registration.
Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.15 |
Dr. Reddys Lab | 1391.95 |
Cipla | 1504.45 |
Lupin | 2373.00 |
Zydus Lifesciences | 1010.20 |
View more.. |